Atai Life Sciences N.V. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 40.22 million compared to USD 152.39 million a year ago. Basic loss per share from continuing operations was USD 0.25 compared to USD 0.98 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.955 USD | +3.44% | -7.78% | +38.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.65% | 316M | |
+23.46% | 44.96B | |
+0.25% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.79% | 26.08B | |
-21.05% | 19.03B | |
+6.27% | 12.75B | |
+29.23% | 12.06B | |
-3.48% | 11.75B |
- Stock Market
- Equities
- ATAI Stock
- News Atai Life Sciences N.V.
- Atai Life Sciences N.V. Reports Earnings Results for the Full Year Ended December 31, 2023